Revision history of "NANO-IMMUNOTHERAPIES AIMED AT RELEVANT INTRACELLULAR TARGETS IN CANCER" (Q3187566)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 00:1600:16, 9 October 2024DG Regio talk contribs 118,336 bytes +5 Changed label, description and/or aliases in pt
  • curprev 00:1600:16, 9 October 2024DG Regio talk contribs 118,331 bytes −10 Set a claim value: summary (P836): ANTIBILIDADES MONOCLONAIS (MABS) BASEADAS NAS TERAPIAS ESTÃO Dentre AS MAIS AVANÇADAS PARA O TRATAMENTO DO CANCRO. O OBJETIVO DAS TÃO PRÓXIMAS TERÁPIAS BASEADAS EM MABS COMERCIALIZADAS É ALCANÇAR OS SEUS OBJETIVOS AO NÍVEL DA MEMBRANA CELULAR DA STROMA. Infelizmente, existem muitas proteínas localizadas no interior das células cancerígenas e outras células relevantes, tais como os fibroblastos associados ao cancro (CAFS), que são críticos para a pro...

7 March 2024

20 December 2023

12 June 2023

10 June 2023

22 February 2023

18 August 2022

  • curprev 06:3706:37, 18 August 2022DG Regio talk contribs 115,942 bytes +82,289 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

11 October 2021

9 October 2021

8 October 2021